CareDx, Inc. (CDNA) stock

CDNANasdaqServices-Medical LaboratoriesFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 12/3033% above fair value

$77.88−1.93 (-2.42%)

Close on Nov 13, 2026Market cap $4.09BP/E 32.6Yield –

CareDx price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

CareDx's price to sales ratio was 9.1× on Nov 11, 2026, against 2.6× a year earlier. Over the last 5 years it ranged from 0.9× to 9.8×, with a median of 2.8×.

Price to Sales Ratio at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	9.1×	+6.4
2025	Dec 31, 2025	2.7×	−0.9
2024	Dec 31, 2024	3.6×	+1.4
2023	Dec 29, 2023	2.2×	+0.3
2022	Dec 30, 2022	1.9×	−6.8
2021	Dec 31, 2021	8.7×	−12.3
2020	Dec 31, 2020	21.0×	+13.0
2019	Dec 31, 2019	8.0×	−6.9
2018	Dec 31, 2018	14.9×	+11.3
2017	Dec 29, 2017	3.5×	+2.0
2016	Dec 30, 2016	1.6×	−1.0
2015	Dec 31, 2015	2.6×	−0.8
2014	Dec 31, 2014	3.4×	–